These findings illustrate that persistent activation of tumor-infiltrating CD8+ T cells could promote the expression of inhibitory receptors, such as NKG2A and PD-1, and facilitate tumor-infiltrating CD8+ T cells to become dysfunctional. The gene discussed is KLRC1; the disease is neoplasm.